Skip to main content

Table 2 The difference between AD tumor /AD RBM for treatment with 177 Lu and 90 Y

From: Tumor and red bone marrow dosimetry: comparison of methods for prospective treatment planning in pretargeted radioimmunotherapy

Patient number

Ratio tumor/RBM dose

Percentage difference

177 Lu

90 Y

7

1.88

2.13

13%

10

5.72

6.54

14%

11

8.84

9.78

11%

12

5.08

7.27

43%

13

4.33

4.33

0%

14

5.26

6.37

21%

15

1.49

2.29

54%

16

0.68

1.06

56%

17

1.46

2.02

39%

18

9.45

8.87

−6%

19

5.11

4.97

−3%

20

0.64

0.99

54%

21

10.91

13.72

26%

  1. A positive difference represents a higher tumor-to-RBM dose ratio in 90Y, and the percentage is calculated compared to the 177Lu ratio. RBM = red bone marrow.